The cancer research program at HealthPartners includes efforts in prevention, screening and early detection, diagnosis, treatment and survivorship. The results from these studies are disseminated and used around the world to provide better care to patients.
Our cancer research experts bring experience and training from a variety of backgrounds that include:
- medical oncology
- medical ethics
- oncology pharmacy
- cancer modeling and economics
- disease treatment consequences
Health services research
HealthPartners Institute is a leader in cancer research, with a diverse team of investigators and partnerships at the local, regional and national level. The Institute is a member of the Cancer Research Network, a nationwide consortium of 14 nonprofit research centers based in large, integrated care delivery systems. Read more about cancer research at the Institute.
Park Nicollet Frauenshuh Cancer Center and HealthPartners and Regions Cancer Care Centers participate in clinical trials because we want to improve your health and quality of life. All of the cancer medications that patients currently use as part of their treatment came from clinical trials. With participation of patients like you, new medications can be approved for use.
Clinical trials are a vital part of cancer care. Trials are the final phase of cancer research in which new treatments are tested. HealthPartners offers cutting-edge research.
HealthPartners has participated for more than 20 years in a local research collaborative called the Metro-Minnesota Community Oncology Research Consortium (MMCORC). MMCORC is a nonprofit research program sponsored by the National Cancer Institute and participating hospitals and clinics. This program provides people in our community access to the newest therapies available for cancer treatment, management of treatment side effects and disease symptoms and cancer prevention.